Researchers found that of 15 patients who'd received a one-time treatment with psilocybin, most were still showing "clinically significant" improvements in anxiety and depression four years later.
from WebMD Health https://ift.tt/3aNT9mU
Researchers found that of 15 patients who'd received a one-time treatment with psilocybin, most were still showing "clinically significant" improvements in anxiety and depression four years later.
The average life expectancy of people with schizophrenia is 10 to 20 years less than in the general population. There has long been concern that one reason is long-term use of antipsychotic drugs to ease symptoms such as delusions and hallucinations.
Early trials in people suggest that such a vaccine can stimulate an immune response very well. But it has never been tried during an outbreak.
Early trials in people suggest that such a vaccine can stimulate an immune response very well. But it has never been tried during an outbreak.